- Home
- USPH
as 07-26-2024 4:00pm EST
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 1.5B | IPO Year: | 1992 |
| Target Price: | $119.50 | AVG Volume (30 days): | 107.2K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.17 | EPS Growth: | -45.58 |
| 52 Week Low/High: | $78.08 - $120.65 | Next Earning Date: | 08-13-2024 |
| Revenue: | $611,968,000 | Revenue Growth: | 7.37% |
| Revenue Growth (this year): | 8.74% | Revenue Growth (next year): | 5.05% |
Stock Insider Trading Activity of U.S. Physical Therapy Inc. (USPH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| READING CHRISTOPHER J | USPH | Chairman of the Board and CEO | May 30 '24 | Sell | $100.26 | 2,900 | $290,754.00 | 95,838 | SEC Form 4 |
| READING CHRISTOPHER J | USPH | Chairman of the Board and CEO | May 28 '24 | Sell | $102.13 | 1,100 | $112,343.00 | 99,738 | SEC Form 4 |
| READING CHRISTOPHER J | USPH | Chairman of the Board and CEO | May 28 '24 | Sell | $100.13 | 1,000 | $100,130.00 | 98,738 | SEC Form 4 |
| KUNTZ EDWARD L | USPH | Director | May 15 '24 | Sell | $107.57 | 2,500 | $268,925.00 | 3,280 | SEC Form 4 |
| REEVE GRAHAM D. | USPH | COO | May 10 '24 | Sell | $105.46 | 1,724 | $181,813.04 | 6,970 | SEC Form 4 |
| Williams Eric Joseph | USPH | Co-Chief Operations Officer | May 10 '24 | Sell | $104.22 | 2,500 | $260,550.00 | 16,814 | SEC Form 4 |
| HENDRICKSON CAREY P | USPH | Chief Financial Officer | Mar 13 '24 | Sell | $107.23 | 12 | $1,286.76 | 22,974 | SEC Form 4 |
| HENDRICKSON CAREY P | USPH | Chief Financial Officer | Mar 13 '24 | Sell | $107.28 | 1,788 | $191,816.64 | 21,186 | SEC Form 4 |
| Binstein Richard | USPH | EVP Gen'l Counsel & Secretary | Mar 13 '24 | Sell | $106.55 | 2,000 | $213,100.00 | 15,006 | SEC Form 4 |
| Trier Clayton | USPH | Director | Mar 13 '24 | Sell | $107.00 | 400 | $42,800.00 | 7,000 | SEC Form 4 |
| HAM NANCY | USPH | Director | Mar 13 '24 | Sell | $107.89 | 500 | $53,945.00 | 860 | SEC Form 4 |
| REEVE GRAHAM D. | USPH | COO | Mar 4 '24 | Sell | $104.39 | 2,629 | $274,441.31 | 6,902 | SEC Form 4 |
| Williams Eric Joseph | USPH | Co-Chief Operations Officer | Mar 4 '24 | Sell | $104.60 | 500 | $52,300.00 | 20,314 | SEC Form 4 |
| Williams Eric Joseph | USPH | Co-Chief Operations Officer | Mar 4 '24 | Sell | $105.14 | 1,000 | $105,140.00 | 19,314 | SEC Form 4 |
| KUNTZ EDWARD L | USPH | Director | Mar 4 '24 | Sell | $104.26 | 2,500 | $260,650.00 | 5,780 | SEC Form 4 |
| Trier Clayton | USPH | Director | Dec 13 '23 | Sell | $92.26 | 1,170 | $107,944.20 | 7,400 | SEC Form 4 |
| Gilmartin Kathleen A | USPH | Director | Nov 10 '23 | Buy | $82.34 | 1,000 | $82,340.00 | 15,480 | SEC Form 4 |
Latest U.S. Physical Therapy Inc. News
USPH Breaking Stock News: Dive into USPH Ticker-Specific Updates for Smart Investing
Zacks
8 hours ago
AMED vs. USPH: Which Stock Is the Better Value Option?
Business Wire
12 hours ago
U.S. Physical Therapy, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call
Argus Research
3 days ago
USPH: Lowering target price to $78.00
Argus Research
10 days ago
USPH: Rating decreased to a SELL
Simply Wall St.
12 days ago
Here's What's Concerning About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Zacks
16 days ago
AMED or USPH: Which Is the Better Value Stock Right Now?
Argus Research
17 days ago
USPH: Lowering target price to $95.00
Zacks
17 days ago
AMED vs. USPH: Which Stock Is the Better Value Option?
Compare USPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "USPH U.S. Physical Therapy Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.